Liraglutide's Efficacy and Safety as Adjunct to Insulin Investigated in Type 1 Diabetes
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
Abstract
Liraglutide's efficacy and safety as an adjunct to insulin therapy in Type 1 Diabetes was the focus of a 52-week, randomized, placebo-controlled trial across multiple continents.
TitrateLab articles covering Liraglutide
Written by TitrateLab, separately from the study summarized above.
